Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer	Head and Neck Neoplasms, Neoplasms by Site, neoplasm	Recruiting	Phase 1 / Phase 2	2025-09-17		NCT05838729

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Coordination Pharmaceuticals, Inc.	2
University of Illinois at Chicago	211

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Illinois at Chicago	Chicago	United States	85

Clinical trials